lipid prodrugs

Science Times - Remdesivir Currently Being Modified from Intravenous to Oral Administration; Study Describes Potential of the Antiviral Drug in Treating COVID-19

Remdesivir Currently Being Modified from Intravenous to Oral Administration; Study Describes Potential of the Antiviral Drug in Treating COVID-19

Medicine & Technology Aug 04, 2021

Researchers are currently working to enhance Remdesivir, the only FDA-approved COVID-19 treatment. From being administered intravenously, it is currently being developed to be orally taken.

lipid prodrugs

Remdesivir Currently Being Modified from Intravenous to Oral Administration; Study Describes Potential of the Antiviral Drug in Treating COVID-19

Most Popular

How Technology Is Changing the Real Estate Industry?

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko Biography, Photo, Career, Accomplishments

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission